Back to Agenda
Digitisation of Systems and Technology (AI)
Session Chair(s)
Pedro Franco, PharmD, PhD, MS, MSc
Senior Director for Global Regulatory & Scientific Policy (GRASP)
Merck Serono Limited, United Kingdom
The digital revolution is a reality and affecting almost every industry. The pharmaceutical industry is no exception to this. Nowadays, digitalisation is changing the healthcare industry. New digitisation of systems and technologies are already allowing pharmaceutical companies to improve medicine development, patient care and internal systems.
Learning Objective : To understand how Regulatory Agencies can use digital technology and artificial intelligence to support assessment and decision-making process. On the other hand, to recognise how Industry can use the same type of technology to predict outcome of the assessment and adjust drug development in order to avoid failure.
Speaker(s)
An example on how to use digital technology and artificial intelligence in decision making process
Pedro Franco, PharmD, PhD, MS, MSc
Merck Serono Limited, United Kingdom
Senior Director for Global Regulatory & Scientific Policy (GRASP)
The Digital Revolution: An FDA Inspector’s Perspective on the Benefits of Advanced Digital Systems
Bryant Headley, MBA
MasterControl, United States
Customer Success Executive/Government
Nadir Ammour, DMD, MBA
Sanofi, France
Global Lead Clinical Innovation & External Engagement
Have an account?